Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortBiologic for psoriasis and spondyloarthritis.Biologic injection for arthritis, IBD and psoriasis.
Body systemJoints & ImmunityJoints & Immunity
Drug classInterleukin inhibitorsTNF inhibitors
SupplyPrescription onlyPrescription only
Main usesPlaque psoriasis, Psoriatic arthritis, Ankylosing spondylitis, Hidradenitis suppurativaRheumatoid and psoriatic arthritis, Ankylosing spondylitis, Crohn's disease and ulcerative colitis, Psoriasis, Hidradenitis suppurativa
How it worksBlocks an inflammation signal central to psoriasis.Mops up a key inflammation signal.
Starts working——
Half-lifeAbout 27 daysAbout 2 weeks
Typical adult dose300 mg weekly for 5 weeks, then every 4 weeks.40 mg under the skin every other week (some conditions start higher or go weekly).
FormsPre-filled pen, IV infusionPre-filled pen, Pre-filled syringe
Common side effectsCold-like infections, Oral thrush, DiarrhoeaInjection-site reactions, Upper respiratory infections, Headache
Serious side effectsNew or worse inflammatory bowel disease, Serious infectionsSerious infections including TB reactivation, Lymphoma (rare), Demyelination, Heart failure worsening
Don't take if——
Alcohol——
PregnancyUse with cautionLimited data.Use with cautionOften continued into pregnancy for IBD; baby's live vaccines may be delayed.
Breastfeeding——
In use since20152002
Brand namesUnited States: CosentyxUnited Kingdom: CosentyxIndia: ScaphoUnited States: Humira, Hadlima, Hyrimoz, YuflymaUnited Kingdom: Humira, Amgevita, Imraldi, YuflymaIndia: Exemptia, Adfrar
Legal status——
ATC codeL04AC10L04AB04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker